|Articles|May 1, 2000

Advances in the Treatment of GERD: A Managed Care Perspective
Volume 6
Issue 9 Suppl

Participating Faculty

Download PDF: Participating Faculty

Articles in this issue

over 26 years ago

Article

Introduction

over 26 years ago

Article

An Overview of Gastroesophageal Reflux Disease

over 26 years ago

Article

New Therapeutic Options in the Treatment of Gastroesophageal Reflux Disease and Other Acid-Peptic Diseases

over 26 years ago

Article

Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

over 26 years ago

Article

Treatment of Gastroesophageal Reflux Disease in a Managed Care Environment

over 26 years ago

Article

Roundtable Discussion

over 26 years ago

Article

A Critical Evaluation of Proton Pump Inhibitors in the Treatment of Gastroesophageal Reflux Disease

over 26 years ago

Article

Selected Abstracts

over 26 years ago

Article

Continuing Medical/Pharmacy Education Quiz

over 26 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Participating Faculty

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning

New York Experts Push for Coordinated Obesity Care Teams

Grocery Assistance Benefit Linked to Fewer Diabetes Complications

CMS Invests $144M to Boost Rural Health Access in Alabama